23rd September 2021
The EIT Health supported start-ups Byteflies and SYNCSENCE were among the four start-ups awarded in the NAM Healthy Longevity QuickFire Challenge by Johnson & Johnson Innovation.
The awards are part of the Healthy Longevity Global Competition – a multiyear, multimillion-dollar international competition seeking breakthrough innovations to extend human health and function later in life. Founded by the U.S. National Academy of Medicine, the competition has been running for two years and calls on teams and individuals from diverse backgrounds including science, medicine, technology, finance, and social sciences to submit novel and innovative ideas. The Competition includes a three-tiered structure of awards: a first phase of Catalyst Awards, a second phase Accelerator Award, and a third Grand Prize phase.
It means the world to us being selected as an Awardee of the NAM Healthy Longevity QuickFire Challenge. This truly set us on fire! The grant funding and mentorship will help us to accelerate our research and development with focus on unlocking the potential for healthy aging globally. This award nicely succeeds our award from EIT Health and we are extremely proud that they believe that we can significantly improve the lives of patients and citizens around the world in an area of high unmet need.
Simon Bruntse Andersen, Co-Founder & CEO, SYNCSENSE ApS
In 2020 Byteflies and SYNCSENCE were awarded by EIT Health for the first tier Catalyst Awards. Their progress since then has been impressive which is why they reached the second tier of the competition. To advance their innovation journey, the four awardees will receive a combined total of $750,000 in grant funding and mentorship opportunities from experts at the Johnson & Johnson Family of Companies.
The NAM Healthy Longevity QuickFire Challenge accelerates our dream to bring our telemonitoring solution for oncology to the market. We’re truly motivated to, together with superb mentorship and support, make a difference and improve quality of life for cancer patients around the globe. We owe many thanks to EIT Health for their support and guidance since we won the catalyst award.
Arno Bossaert, Byteflies
Byteflies (Belgium): Byteflies is creating a hematology-oncology-specific digital health solution with the potential to objectively track disease progression and detect treatment adverse effects such as neurotoxicity and inflammation at an early stage.
SYNCSENSE (Denmark): With a proprietary intelligent AI-driven sensor and a VR platform, SYNCSENSE aims to transform exercise equipment into engaging and adaptive exergaming experiences that prevents and treats diseases related to physical inactivity and aging.